Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herena Eixarch

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Trends in Molecular Medicine|February 20, 2013
Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosisHerena Eixarch, Ana Gutiérrez-Franco, Xavier Montalban, et al.
Autoimmunity Reviews|December 2, 2017
Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosisLaura Calvo-Barreiro, Herena Eixarch, Xavier Montalban, et al.
Brain, Behavior, and Immunity|March 3, 2017
Bone morphogenetic proteins in multiple sclerosis: Role in neuroinflammationHerena Eixarch, Laura Calvo-Barreiro, Xavier Montalban, et al.
International Journal of Molecular Sciences|June 27, 2024
IL-6 Inhibition as a Therapeutic Target in Aged Experimental Autoimmune EncephalomyelitisMaría Dema, Herena Eixarch, Mireia Castillo, et al.
Autoimmunity Reviews|July 8, 2021
Immunosenescence in multiple sclerosis: the identification of new therapeutic targetsMaría Dema, Herena Eixarch, Luisa M Villar, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 28, 2022
Therapeutic Effect of IL-21 Blockage by Gene Therapy in Experimental Autoimmune EncephalomyelitisÁngel Edo, Laura Calvo-Barreiro, Herena Eixarch, et al.
Aging Cell|February 2, 2025
Disease Aggravation With Age in an Experimental Model of Multiple Sclerosis: Role of ImmunosenescenceMaría Dema, Herena Eixarch, Arnau Hervera, et al.
Cells|December 24, 2021
Immunomodulatory Effects Associated with Cladribine TreatmentNicolás Fissolo, Laura Calvo-Barreiro, Herena Eixarch, et al.
Neuroscience Letters|March 8, 2013
Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosisHerena Eixarch, M José Mansilla, Carme Costa, et al.
Signal Transduction and Targeted Therapy|October 1, 2025
Multiple sclerosis: molecular pathogenesis and therapeutic interventionImane Boutitah-Benyaich, Herena Eixarch, Javier Villacieros-Álvarez, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Trends in Molecular Medicine|February 20, 2013
Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosisHerena Eixarch, Ana Gutiérrez-Franco, Xavier Montalban, et al.
Autoimmunity Reviews|December 2, 2017
Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosisLaura Calvo-Barreiro, Herena Eixarch, Xavier Montalban, et al.
Brain, Behavior, and Immunity|March 3, 2017
Bone morphogenetic proteins in multiple sclerosis: Role in neuroinflammationHerena Eixarch, Laura Calvo-Barreiro, Xavier Montalban, et al.
International Journal of Molecular Sciences|June 27, 2024
IL-6 Inhibition as a Therapeutic Target in Aged Experimental Autoimmune EncephalomyelitisMaría Dema, Herena Eixarch, Mireia Castillo, et al.
Autoimmunity Reviews|July 8, 2021
Immunosenescence in multiple sclerosis: the identification of new therapeutic targetsMaría Dema, Herena Eixarch, Luisa M Villar, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 28, 2022
Therapeutic Effect of IL-21 Blockage by Gene Therapy in Experimental Autoimmune EncephalomyelitisÁngel Edo, Laura Calvo-Barreiro, Herena Eixarch, et al.
Aging Cell|February 2, 2025
Disease Aggravation With Age in an Experimental Model of Multiple Sclerosis: Role of ImmunosenescenceMaría Dema, Herena Eixarch, Arnau Hervera, et al.
Cells|December 24, 2021
Immunomodulatory Effects Associated with Cladribine TreatmentNicolás Fissolo, Laura Calvo-Barreiro, Herena Eixarch, et al.
Neuroscience Letters|March 8, 2013
Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosisHerena Eixarch, M José Mansilla, Carme Costa, et al.
Signal Transduction and Targeted Therapy|October 1, 2025
Multiple sclerosis: molecular pathogenesis and therapeutic interventionImane Boutitah-Benyaich, Herena Eixarch, Javier Villacieros-Álvarez, et al.
Pageof 4